scholarly journals Do Lung surfactant proteins play a role in severity of bronchiolitis

2021 ◽  
Vol 3 (4) ◽  
pp. 122-124
Author(s):  
Niranjan Biswal ◽  
Rachel Poorna Rudhan
2013 ◽  
Vol 54 (4) ◽  
pp. 2571 ◽  
Author(s):  
Chendur K. Palaniappan ◽  
Burkhardt S. Schütt ◽  
Lars Bräuer ◽  
Martin Schicht ◽  
Thomas J. Millar

Biochemistry ◽  
1991 ◽  
Vol 30 (45) ◽  
pp. 10965-10971 ◽  
Author(s):  
Marja A. Oosterlaken-Dijksterhuis ◽  
Henk P. Haagsman ◽  
Lambert M. G. Van Golde ◽  
Rudy A. Demel

1990 ◽  
Vol 259 (4) ◽  
pp. L185-L197
Author(s):  
B. R. Stripp ◽  
J. A. Whitsett ◽  
D. L. Lattier

Gene transcription is regulated by the formation of protein-DNA complexes that influence the rate of specific initiation of transcription by RNA polymerase. Recent experimental advances allowing the identification of cis regulatory sequences that specify the binding of trans acting protein factors have made significant contributions to our understanding of the mechanistic complexities of transcriptional regulation. These methodologies have prompted the use of similar strategies to elucidate transcriptional control mechanisms involved in the tissue specific and developmental regulation of pulmonary surfactant protein gene expression. The purpose of this review is to describe various methodologies by which molecular biologists identify and subsequently assay regions of nucleic acids presumed to be integral in gene regulation at the level of transcription. It is well established that genes encoding surfactant proteins are subject to regulation by hormones, cytokines, and a variety of biologically active reagents. Perhaps future studies utilizing molecular tools outlined in this review will be valuable in identification of DNA sequences and protein factors required for the regulation of lung surfactant genes.


2001 ◽  
Vol 163 (2) ◽  
pp. 389-397 ◽  
Author(s):  
SHANJANA AWASTHI ◽  
JACQUELINE J. COALSON ◽  
BRADLEY A. YODER ◽  
ERIKA CROUCH ◽  
RICHARD J. KING

1999 ◽  
Vol 11 (1) ◽  
pp. 28-33 ◽  
Author(s):  
Paul Eggleton ◽  
Kenneth BM Reid

1997 ◽  
Vol 328 (1) ◽  
pp. 251-256 ◽  
Author(s):  
Bernadette CHAILLEY-HEU ◽  
Sandrine RUBIO ◽  
Jean-Philippe ROUGIER ◽  
Robert DUCROC ◽  
Anne-Marie BARLIER-MUR ◽  
...  

Human peritoneal dialysis effluent (PDE) contains a phosphatidylcholine-rich compound similar to the surfactant that lines lung alveoli. This material is secreted by mesothelial cells. Lung surfactant is also characterized by four proteins essential to its function. After having long been considered as lung-specific, some of them have been found in gastric and intestinal epithelial cells. To explore further the similarity between lung and peritoneal surfactants, we investigated whether mesothelial cells also produce surfactant proteins. We used rat transparent mesentery, human visceral peritoneum biopsies and PDE. Surfactant proteins were searched for after one- and two-dimensional SDS/PAGE and Western blotting. On a one-dimensional Western blot, bands at 38 and 66 kDa in rat mesentery, and at 38 and 66 kDa in human peritoneal mesothelial cells (in vivo and in vitro) and PDE, corresponded to monomeric and dimeric forms of lung surfactant protein A (SP-A). On two-dimensional Western blots, the 32 and 38 kDa spots in mesentery and PDE localized at the acidic pH appropriate to the SP-A monomer's isoelectric point. SP-D was also identified at the same 43 kDa molecular mass as in lung. SP-B was not detected in mesenteric samples. Expression of SP mRNA species was also assessed by reverse transcriptase-PCR, which was performed with specific primers of surfactant protein cDNA sequences. With primers of SP-A and SP-D, DNA fragments of the same size were amplified in lung and mesentery, indicating the presence of SP-A and SP-D mRNA species. These fragments were labelled by appropriate probes in a Southern blot. No amplification was obtained for SP-B. These results show that mesentery cells produce SP-A and SP-D, although they are of embryonic origin (mesodermal) and are different from those of the lung and digestive tract (endodermal) that secrete these surfactants.


2003 ◽  
Vol 285 (3) ◽  
pp. L550-L559 ◽  
Author(s):  
Z. Wang ◽  
A. L. Schwan ◽  
L. L. Lairson ◽  
J. S. O'Donnell ◽  
G. F. Byrne ◽  
...  

Surface activity and sensitivity to inhibition from phospholipase A2 (PLA2), lysophosphatidylcholine (LPC), and serum albumin were studied for a synthetic C16:0 diether phosphonolipid (DEPN-8) combined with 1.5% by weight of mixed hydrophobic surfactant proteins (SP)-B/C purified from calf lung surfactant extract (CLSE). Pure DEPN-8 had better adsorption and film respreading than the major lung surfactant phospholipid dipalmitoyl phosphatidylcholine and reached minimum surface tensions <1 mN/m under dynamic compression on the Wilhelmy balance and on a pulsating bubble surfactometer (37°C, 20 cycles/min, 50% area compression). DEPN-8 + 1.5% SP-B/C exhibited even greater adsorption and had overall dynamic surface tension lowering equal to CLSE on the bubble. In addition, films of DEPN-8 + 1.5% SP-B/C on the Wilhelmy balance had better respreading than CLSE after seven (but not two) cycles of compression-expansion at 23°C. DEPN-8 is structurally resistant to degradation by PLA2, and DEPN-8 + 1.5% SP-B/C maintained high adsorption and dynamic surface activity in the presence of this enzyme. Incubation of CLSE with PLA2 led to chemical degradation, generation of LPC, and reduced surface activity. DEPN-8 + 1.5% SP-B/C was also more resistant than CLSE to direct biophysical inhibition by LPC, and the two were similar in their sensitivity to biophysical inhibition by serum albumin. These findings indicate that synthetic surfactants containing DEPN-8 combined with surfactant proteins or related synthetic peptides have potential utility for treating surfactant dysfunction in inflammatory lung injury.


Sign in / Sign up

Export Citation Format

Share Document